A Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonist in Kidney Transplant Recipients With Type 2 Diabetes

Diabetic kidney disease (DKD), a devastating complication of diabetes, is one of the leading causes of end stage kidney disease (ESKD). Kidney transplantation provides superior outcomes for ESKD patients with type 2 diabetes, giving opportunities to be free from dialysis, but needs lifetime immunosu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Tetsuhiko, Ohara, Emi, Ozone, Chikafumi, Okazaki, Mikako, Fuse, Sachiho, Sasaki, Rie, Azuma, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090345/
http://dx.doi.org/10.1210/jendso/bvab048.826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090345/
http://dx.doi.org/10.1210/jendso/bvab048.826

Ejemplares similares